Literature DB >> 16813595

Neurofibromin: a general outlook.

A B Trovó-Marqui1, E H Tajara.   

Abstract

Neurofibromin is a cytoplasmic protein that is predominantly expressed in neurons, Schwann cells, oligodendrocytes, astrocytes and leukocytes. It is encoded by the gene NF1, located on chromosome 17, at q11.2, and has different biochemical functions, including association to microtubules and participation in several signaling pathways. Alterations in this protein are responsible for a phacomatosis named neurofibromatosis type 1.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16813595     DOI： 10.1111/j.1399-0004.2006.00639.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN： 0009-9163            Impact factor:   4.438


  58 in total

1.  Cell of origin and microenvironment contribution for NF1-associated dermal neurofibromas.

Authors:  Lu Q Le; Tracey Shipman; Dennis K Burns; Luis F Parada
Journal:  Cell Stem Cell       Date:  2009-05-08       Impact factor: 24.633

2.  Neurofibromatosis: chronological history and current issues.

Authors:  João Roberto Antônio; Eny Maria Goloni-Bertollo; Lívia Arroyo Trídico
Journal:  An Bras Dermatol       Date:  2013 May-Jun       Impact factor: 1.896

3.  In vitro modeling of hyperpigmentation associated to neurofibromatosis type 1 using melanocytes derived from human embryonic stem cells.

Authors:  Jennifer Allouche; Nathalia Bellon; Manoubia Saidani; Laure Stanchina-Chatrousse; Yolande Masson; Anand Patwardhan; Floriane Gilles-Marsens; Cédric Delevoye; Sophie Domingues; Xavier Nissan; Cécile Martinat; Gilles Lemaitre; Marc Peschanski; Christine Baldeschi
Journal:  Proc Natl Acad Sci U S A       Date:  2015-07-06       Impact factor: 11.205

4.  CanProVar: a human cancer proteome variation database.

Authors:  Jing Li; Dexter T Duncan; Bing Zhang
Journal:  Hum Mutat       Date:  2010-03       Impact factor: 4.878

Review 5.  Inherited pancreatic endocrine tumor syndromes: advances in molecular pathogenesis, diagnosis, management, and controversies.

Authors:  Robert T Jensen; Marc J Berna; David B Bingham; Jeffrey A Norton
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

6.  A brother and sister with breast cancer, BRCA2 mutations and bilateral supernumerary nipples.

Authors:  Michael McKay; Ryan Coad
Journal:  Ann Transl Med       Date:  2017-03

7.  Absence of exon 17 c.2970-2872delAAT mutation in Turkish NF1 patients with mild phenotype.

Authors:  Yunus Kasim Terzi; Burcu Sirin; Esra Serdaroglu; Banu Anlar; Sabiha Aysun; Guzen Hosgor; Elif Acar Arslan; Sukriye Ayter
Journal:  Childs Nerv Syst       Date:  2011-07-06       Impact factor: 1.475

Review 8.  Moving towards a paradigm: common mechanisms of chemotactic signaling in Dictyostelium and mammalian leukocytes.

Authors:  Yulia Artemenko; Thomas J Lampert; Peter N Devreotes
Journal:  Cell Mol Life Sci       Date:  2014-05-21       Impact factor: 9.261

9.  Medium throughput biochemical compound screening identifies novel agents for pharmacotherapy of neurofibromatosis type 1.

Authors:  Galina Semenova; Dina S Stepanova; Sergey M Deyev; Jonathan Chernoff
Journal:  Biochimie       Date:  2017-01-06       Impact factor: 4.079

10.  Treatment of neurofibromatosis type 1.

Authors:  Caterina Sabatini; Donatella Milani; Francesca Menni; Gianluca Tadini; Susanna Esposito
Journal:  Curr Treat Options Neurol       Date:  2015-06       Impact factor: 3.598
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.